 "money, cash, investment, stocks, tax, funds, investors, investment, shares, lenders, lending, loans, funding")
API Holdings, the parent company of PharmEasy, has acquired a majority stake in healthcare supply chain start-up Aknamed for an initial investment of Rs 308 crore. Sources said PharmEasy will complete the acquisition in a few months, with the total deal size being about Rs 1,000 crore. This will be the third acquisition by PharmEasy this year.
PharmEasy, which is planning an IPO, has acquired 975,937 equity shares in the company, said a regulatory filing. The founders of Aknamed will continue to be with the company and join API Holdings, sources said.
There had been reports that PharmEasy
PharmEasy, which is planning an IPO, has acquired 975,937 equity shares in the company, said a regulatory filing. The founders of Aknamed will continue to be with the company and join API Holdings, sources said.
There had been reports that PharmEasy
